VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 190 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 2.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $855,568 | +29.7% | 151,428 | -5.6% | 0.00% | 0.0% |
| Q1 2024 | $659,536 | -37.8% | 160,471 | -36.1% | 0.00% | -50.0% |
| Q4 2023 | $1,059,798 | -21.8% | 251,137 | -19.9% | 0.00% | 0.0% |
| Q3 2023 | $1,354,834 | +2.5% | 313,619 | +56.4% | 0.00% | 0.0% |
| Q2 2023 | $1,321,163 | -75.6% | 200,480 | -74.9% | 0.00% | -77.8% |
| Q1 2023 | $5,414,291 | +216.0% | 797,392 | +243.9% | 0.01% | +200.0% |
| Q4 2022 | $1,713,607 | -9.6% | 231,882 | +20.8% | 0.00% | 0.0% |
| Q3 2022 | $1,896,000 | +6220.0% | 191,964 | +6778.0% | 0.00% | – |
| Q2 2022 | $30,000 | -96.8% | 2,791 | -96.7% | 0.00% | -100.0% |
| Q1 2022 | $947,000 | -40.2% | 83,796 | -17.0% | 0.00% | -50.0% |
| Q4 2021 | $1,584,000 | – | 100,977 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 728,000 | $10,425,000 | 5.01% |
| Signpost Capital Advisors, LP | 828,793 | $11,868,000 | 4.38% |
| Palo Alto Investors LP | 3,786,908 | $54,229,000 | 3.18% |
| RTW INVESTMENTS, LP | 500,000 | $7,160,000 | 2.65% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,139,787 | $59,282,000 | 2.13% |
| First Light Asset Management, LLC | 229,818 | $3,291,000 | 1.86% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,461,305 | $35,246,000 | 1.53% |
| PURA VIDA INVESTMENTS, LLC | 175,000 | $2,506,000 | 0.92% |
| WALL STREET ASSOCIATES | 655,800 | $9,391,000 | 0.90% |
| SPHERA FUNDS MANAGEMENT LTD. | 368,390 | $5,275,000 | 0.90% |